TREPPO, Elena
 Distribuzione geografica
Continente #
NA - Nord America 1.066
AS - Asia 1.039
EU - Europa 393
SA - Sud America 178
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 26
OC - Oceania 4
AN - Antartide 1
Totale 2.851
Nazione #
US - Stati Uniti d'America 1.020
SG - Singapore 505
CN - Cina 169
BR - Brasile 146
VN - Vietnam 124
IT - Italia 110
HK - Hong Kong 103
RU - Federazione Russa 55
FR - Francia 45
DE - Germania 41
CA - Canada 26
FI - Finlandia 24
KR - Corea 23
IN - India 22
GB - Regno Unito 21
BD - Bangladesh 19
AR - Argentina 14
IE - Irlanda 14
AT - Austria 13
PL - Polonia 13
NL - Olanda 12
PK - Pakistan 11
JP - Giappone 10
SE - Svezia 10
ZA - Sudafrica 10
IQ - Iraq 9
ID - Indonesia 8
UZ - Uzbekistan 7
CO - Colombia 6
ES - Italia 6
MX - Messico 6
BE - Belgio 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
GR - Grecia 4
TG - Togo 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
HR - Croazia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
OM - Oman 3
UA - Ucraina 3
CH - Svizzera 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
HN - Honduras 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.708
Città #
Singapore 236
Ashburn 168
Council Bluffs 105
San Jose 99
Hong Kong 95
Beijing 73
Boardman 54
Ho Chi Minh City 34
Los Angeles 34
Lauterbourg 33
Chandler 29
Hefei 25
Santa Clara 25
Hanoi 23
Seoul 23
Dallas 22
New York 22
Milan 18
Redondo Beach 17
Helsinki 16
Frankfurt am Main 15
São Paulo 15
Buffalo 14
Dublin 14
The Dalles 13
Warsaw 13
Dong Ket 12
Nuremberg 12
Ann Arbor 11
Belluno 11
Wilmington 10
Denver 9
Düsseldorf 9
Houston 9
Seattle 9
Woodbridge 9
Lappeenranta 8
Mumbai 8
Princeton 8
Stockholm 8
Tokyo 8
Toronto 8
Udine 8
Amsterdam 7
Brooklyn 7
Fairfield 7
London 7
Tashkent 7
Cambridge 6
Johannesburg 6
Lahore 6
Ogden 6
Phoenix 6
Biên Hòa 5
Chicago 5
Florence 5
Haiphong 5
Montreal 5
Taranto 5
Vienna 5
Athens 4
Atlanta 4
Boston 4
Brussels 4
Charlotte 4
Chennai 4
Da Nang 4
Jakarta 4
Lomé 4
Newark 4
North Bergen 4
Orem 4
Rimini 4
Trieste 4
Xi'an 4
Campinas 3
Christchurch 3
Colombo 3
Crema 3
Des Moines 3
Guarulhos 3
Hải Dương 3
Jacksonville 3
Lucca 3
Memphis 3
Milwaukee 3
Querétaro 3
Rio de Janeiro 3
Rosario 3
San Francisco 3
Semarang 3
Vũng Tàu 3
Albufeira 2
Amman 2
Ankara 2
Asunción 2
Basra 2
Belo Horizonte 2
Bergamo 2
Bogotá 2
Totale 1.619
Nome #
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 133
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 120
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 116
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 113
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 107
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren's disease: a monocentric cohort study 100
Sjögren's disease and systemic lupus erythematosus overlap syndrome as distinct entity at the crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both diseases 99
Systemic vasculitis: one year in review 2023 98
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 97
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 95
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 92
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 90
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 90
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 86
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 84
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 84
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres 84
Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome 82
Systemic vasculitis: one year in review 2024 79
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 78
Systemic vasculitis: one year in review 2022 76
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 75
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 74
Paraproteinemias Associated with Autoimmune Diseases 70
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 70
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis 67
Rheumatologic manifestations of Hepatitis C Virus 63
Mass-Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report 62
One year in review 2020: vasculitis 61
One year in review 2021: systemic vasculitis 60
Systemic vasculitis: one year in review 2025 56
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 55
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets 46
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 39
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature 36
Systemic vasculitis: one year in review 2026 14
Totale 2.851
Categoria #
all - tutte 13.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 0 0 6 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/2025839 14 73 44 28 35 31 83 69 118 61 143 140
2025/20261.542 150 165 129 114 247 149 144 44 73 103 134 90
2026/2027140 36 79 25 0 0 0 0 0 0 0 0 0
Totale 2.851